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Introduction
Collagen accounts for about two-thirds of the dry weight
of adult articular cartilage. The tissue’s material strength
depends on the extensive cross-linking of the collagen and
the apparent zonal changes in fibrillar architecture with
tissue depth. Once laid down during development, there
appears to be little capacity for articular chondrocytes to
recapitulate the overall collagen architecture if the mature
tissue is injured or undergoes advanced degenerative
changes. The ability of chondrocytes to remodel the colla-
gen at ultrastructural and molecular levels is poorly under-
stood, but it may be more significant than previously
thought and possible molecular mechanisms are a topic of
growing interest.
The four zones of articular cartilage visible by light
microscopy (superficial or tangential, intermediate or tran-
sitional, deep or radial, and calcified) differ in their colla-
gen fibril orientation [1]. In general, collagen fibrils seen by
transmission electron microscopy (TEM) (Fig. 1) form a
random network compared with those of other connective
tissues but, both macroscopically and ultrastructurally,
preferred fibril patterns are evident [2]. In the superficial
zone (~200 µm), the fibrils are thin and tend to run primar-
ily parallel to the plane of the articular surface with some
degree of parallel orientation in that plane. A greater range
of fibril diameters is seen in the deeper zones, and the
organization appears more random when viewed by TEM.
In the radial zone of some joint regions, a preferred orien-
tation of fibril bundles orthogonal to the surface can be
seen by scanning electron microscopy, also visible by
TEM in regions of pathologically softened cartilage [2].
The arcade-like macro-architecture of collagen responsi-
ble for this zonal appearance described by Benninghoff
[3] appears, on scanning electron microscopy, to reflect a
folding over of radial fiber bundles to lie in the plane of the
surface in a series of layers or leaflets that makes up the
tangential zone [4]. In mammalian articular cartilage, the
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Abstract
The extracellular framework and two-thirds of the dry mass of adult articular cartilage are polymeric
collagen. Type II collagen is the principal molecular component in mammals, but collagens III, VI, IX, X,
XI, XII and XIV all contribute to the mature matrix. In developing cartilage, the core fibrillar network is a
cross-linked copolymer of collagens II, IX and XI. The functions of collagens IX and XI in this
heteropolymer are not yet fully defined but, evidently, they are critically important since mutations in
COLIX and COLXI genes result in chondrodysplasia phenotypes that feature precocious osteoarthritis.
Collagens XII and XIV are thought also to be bound to fibril surfaces but not covalently attached.
Collagen VI polymerizes into its own type of filamentous network that has multiple adhesion domains
for cells and other matrix components. Collagen X is normally restricted to the thin layer of calcified
cartilage that interfaces articular cartilage with bone.
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primary collagen components (collagens II, IX and XI) do
not appear to alter dramatically in proportion between
zones. (In birds, type I collagen predominates at the articu-
lar surface and decreases with depth in an interchanging
gradient with type II collagen [5].) The greatest quantitative
difference occurs with maturation from the exclusively fine
fibrils of young growth cartilages (≥10% collagen IX, ≥10%
collagen XI, ≤80% collagen II) to the thicker and more
varied fibril diameters of mature articular cartilage (~1%
collagen IX, ~3% collagen XI, ≥90% collagen II) [6].
The collagen phenotype of the calcified zone of cartilage
that interfaces with bone also includes type X collagen
surrounding the cells, as in the hypertrophic zone of the
growth plate [7].
Ultrastructural fabric
In finer detail, the fibrillar appearance of the mature tissue
differs for the pericellular and the intercellular (interterritor-
ial) matrix. Fibrils become coarser and more obviously
banded, as seen by TEM, going further from the chondro-
cyte [1]. The proportion of type IX [8] and type XI [9] colla-
gens is highest in the thinnest fibrils that form the
pericellular basket, or the chondron described by Poole et
al. [8]. Remodeling and maturation of thin, newly made
fibrils presumably involves removal of collagens IX and XI,
and/or their dilution by addition of new type II collagen. To
what degree thin fibrils fuse laterally in the matrix versus
growing by accretion of new monomers is unclear,
although both processes are thought to occur [10,11].
The collagen II:IX:XI heteropolymer
Collagens II, IX and XI resist extraction with denaturants or
serial digestion with streptomyces hyaluronidase, chon-
droitinase ABC, and trypsin at 37°C. Such serial digestion
leaves little else in the cartilage but these three collagens
as cross-linked polymers [12]. The exact spatial relation-
ships, manner and temporal order of assembly of these
different collagen types into heteromeric fibrils are not well
understood. Their interaction and existence as subunits of
the same fibril network have been shown by immunoelec-
tron microscopy [13] and the isolation and structural iden-
tification of cross-linked heterotypic peptides [14,15]. The
basic structure of the fibrils seen by TEM is a four-dimen-
sional (4D)-staggered polymer of collagen type II mole-
cules heavily cross-linked head-to-tail by hydroxylysyl
pyridinoline residues at the two telopeptide-to-helix sites.
Collagen IX molecules can decorate fibril surfaces, partic-
ularly those of thin fibrils in the pericellular basket [16].
Cross-linking studies have identified at least six sites of
cross-linking within the collagen IX molecule where cova-
lent bonds form with either collagen II molecules or with
other collagen IX molecules [14,17,18] (Eyre D, Wu J,
Weis M, unpublished observations, 2001; Fig. 2). The
cross-linking residues are either trivalent pyridinolines or
divalent borohydride-reducible intermediates formed by
the same lysyl oxidase-mediated mechanism as occurs in
the major fibril-forming collagens.
Each of the three collagen IX chains, α1(IX), α2(IX), and
α3(IX), has one to three cross-linking sites, all of which are
occupied in the matrix pool of type IX collagen, as judged
from peptide mapping studies [17]. The role of collagen IX
in the matrix apparently requires the molecules to be cova-
lently linked to the surface of type II collagen fibrils, which
suggests a mechanical restraint of some kind. It is tempt-
ing to speculate from the biochemical evidence that colla-
gen IX can also form a covalent bridge between fibrils,
increasing network mechanical integrity and providing a
restraint for entrapped proteoglycan osmotic swelling
pressure. Interfibrillar cross-linking has not been proven,
however, and it could be that covalently anchored molecu-
lar projections from fibril surfaces (the COL3 domain and
terminal NC4 globular domain of α1(IX) project from the
fibril surfaces) could restrict shear strains between fibrils
in a mesh of thin fibrils embedded in a proteoglycan gel,
without a need for direct covalent bonds between fibrils.
Figure 2 shows how collagen IX molecules can be accom-
modated on a fibril surface and can satisfy all the covalent
interactions so far identified. In this model proposed by
Miles et al. [19], the COL1/NC1 domain docks in the hole
region, oriented as shown in Figure 2, and the molecule
hinges back on itself at the NC2 domain.
Collagen XI is found in developing cartilage as a het-
erotrimeric molecule of two novel collagen gene products
(α1(XI) and α2(XI)) and a third chain (α3(XI)) identical in
primary sequence to α1(II)B, the common form of splicing
variant of the type II collagen gene [6]. From mature articu-
lar cartilage, the isolated collagen XI fraction contains
Figure 1
The chondrocyte and extracellular matrix of articular cartilage showing the
underlying collagen fibril meshwork (transmission electron microscopy).Arthritis Research    Vol 4 No 1 Eyre
α1(V) and α1(XI) in roughly equal amounts [6]. The α1(V)
chain appears to occur in hybrid molecules together with
α1(XI) and/or α2(XI) rather than in typical type V collagen
molecules found in non-cartilaginous tissues. The biologi-
cal significance of this is unknown.
The N-propeptide domains of all these chains are retained
in the matrix and alternatively spliced variants can be
expressed [20]. Selective binding interactions with other
matrix macromolecules can be expected as part of the dis-
tinctive function of these molecules. Immunolocalization
studies [13] and analyses of cross-linked peptides [15]
have shown that the collagen XI pool is intimately copoly-
merized with type II collagen. The type XI N-propeptide
domains are thought to poke out of the hole domains of the
collagen 4D-staggered lattice, perhaps acting to limit
growth in fibril diameters [20]. Collagen XI is most concen-
trated in the pericellular network of thin fibrils, and recent
work has shown high-affinity binding sites for heparan and
heparin sulfate in the triple helical domains [9].
Cross-linked peptide analyses have shown that collagen XI
molecules are cross-linked to each other through their N-
telopeptide-to-helix interaction sites [15]. They lack a
cross-linking lysine in the C-telopeptide except in the
α3(XI) (αI(II)) chain. Interestingly, the N-telopeptide cross-
linking lysines are located external to candidate metallopro-
teinase cleavage sites, in α1(XI), α1(V) and α2(XI), imply-
ing that any such cleavages could selectively depolymerize
collagen XI [15]. The N-terminal helical cross-linking site of
collagen XI molecules was occupied (in α1(XI)) by the
α1(II)C-telopeptide. By analogy to findings with the type I/V
collagen heteromer of bone [21], this is consistent with the
formation of lateral cross-links between collagen II and XI
molecules at this locus. Together, these findings can be
interpreted as collagen XI initially forming a head-to-tail self-
cross-linked filament that becomes integrated and cross-
linked laterally onto or within the body of collagen II fibrils.
Collagen XI could conceivably form an interconnecting,
secondary filamentous network that provides links between
fibrils as well as running within fibrils, not inconsistent with
the current concept that collagen XI restricts the lateral
growth of collagen II fibrils [22]. Clearly, the majority of the
covalent links of collagen XI are type XI to type XI [15] and
this fact needs to be accommodated in any workable
model of fibril assembly.
Proteolytic and mechanical damage to the fibrillar network
is believed to be a key, perhaps irreversible, stage in the
destruction of joint cartilages in arthritis. Defining and
being able to monitor the structure, assembly and biologi-
cal mechanisms of degradation of the cartilage collagen
Figure 2
The collagen II:IX:XI heterofibril. A molecular model of the collagen type IX fold and interaction site with a collagen II microfibril that can account for
all known cross-linking sites between collagen II and IX molecules.
930
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working modelheterotypic polymer are therefore important for the devel-
opment and validation of rational therapeutic targets for
treating and preventing joint disease.
Collagen type III
Collagen type III is consistently detected by immunofluo-
rescence in samples of normal and osteoarthritic human
articular cartilage [23,24]. By electron microscopy study, it
has been found to colocalize with type II collagen in the
same banded fibrils and to retain its N-propeptide domain
[25]. Cross-linking studies confirm that type III collagen is
copolymerized and linked to collagen II in human articular
cartilage as a minor but regular component [26]. In
osteoarthritic cartilage, collagen III tended to be concen-
trated in the superficial and upper middle zones and to be
synthesized by the chondrocytes in the absence of colla-
gen I expression [23]. It is tempting to speculate that col-
lagen III is made by chondrocytes in addition to collagen II
in response to matrix damage akin to the wound-healing
role of collagen III in type I collagen-based tissues.
Collagens VI, XII and XIV
Type VI collagen is a ubiquitous matrix constituent of most
tissues, including articular cartilage (≤1% of the collagen)
[27]. This protein self-assembles into disulfide-bonded
dimers, tetramers and a distinctive filamentous network
that is most concentrated around cells [28] but also inter-
spersed loosely in spaces throughout the fibrillar matrix.
Among different cartilage types, collagen VI is most con-
centrated in fibrocartilages such as the meniscus and the
intervertebral disc [27]. Type XII and XIV collagens are
two members of the FACIT collagen subfamily, in addition
to collagen IX, that can be extracted from the cartilage
matrix [29]. The FACIT molecules share sequence similari-
ties, most conserved in their COL1 domains [30]. The pro-
teins can be extracted without proteolysis, so they appear
not to be covalently polymerized in the matrix [29], but are
thought to bind physically to collagen fibril surfaces via
their COL1/NC1 domains. Their function is unknown, but
cooperation and/or competition between them and various
other fibril-binding proteins in cartilage, notably the
leucine-repeat small proteoglycans, decorin, biglycan and
fibromodulin, seems probable.
Assembly and turnover
After skeletal growth has ceased, the synthetic rate of type
II collagen by articular chondrocytes drops dramatically as
assessed by proline labeling in vivo. In the adult tissue,
however, some synthesis continues, and this can be
accelerated up to 10-fold within 2 weeks after joint injury,
for example after anterior cruciate ligament section in the
mature dog [31]. Little is known of synthetic rates of the
other collagen types in adult articular cartilage. Observa-
tions based on the synthetic rate of hydroxyproline indi-
cate very little turnover of the collagenous component of
the matrix as a whole, with an estimated turnover time of
400 years for human femoral head cartilage [32]. This still
leaves the possibility that a subfraction of the collagenous
matrix (e.g. fibril surface molecules and the pericellular
domain) is remodeled more rapidly by chondrocytes in
response to mechanical and molecular signals. If the bulk
of the collagen mass, which is embodied in the thicker,
mature fibrils of the interterritorial matrix, persists in matu-
rity without turnover, then the average turnover rate of the
collagen as a whole would still be very slow. Indeed, the
mean diameter of banded collagen fibrils in mature human
articular cartilage increases with age [1], consistent with
this remodeling concept.
It will be important to define how chondrocytes control the
assembly of the heterotypic fibril polymer. Studies on a rat
chondrosarcoma cell line that fails to remove the N-
propeptides from collagen II show that, although fibril
growth is arrested at the stage of fine filaments, collagens
II, IX and XI are already cross-linked in fetal proportions
[33]. Is an initial protofibril containing collagens II, IX and
XI preassembled from monomers as early as a secretory
organelle or are, for example, collagen IX monomers
secreted that can interact with either nascent or mature
fibrils outside the cell? Are collagen XI 4D-staggered fila-
ments assembled independently and do they provide the
template intracellularly or extracellularly for collagen II fibril
growth? By building on such studies and knowledge
derived from studying procollagen I assembly into fibrils in
vitro, and using antibodies and other imaging techniques
to study fibrils in tissues by electron microscopy [34],
these questions should be answerable.
Mechanisms of degradation
Tissue sites of proteolysis and denaturation of matrix type
II collagen can be observed in normal and osteoarthritic
joint surfaces [35] using specific antibodies. The classical
concept of collagen fibril degradation is through an initial
cleavage of the collagen molecule (type I, II or III) by colla-
genase into three-quarter and one-quarter length frag-
ments. Articular chondrocytes can express collagenases,
including collagenase-3 (MMP13) (which is the most
active in cleaving type II collagen), as demonstrated in
culture under interleukin-1 stimulation or directly in tissue
removed from arthritic joints [36]. This enzyme, therefore,
is implicated in the breakdown of cartilage collagen in
osteoarthritis. Of the growing number of matrix metallopro-
teinases that may contribute to matrix protein metabolism
[37], the collagenases are perhaps the best understood in
terms of their natural substrate. However, an essential role
for collagenases in all forms of collagen breakdown and
turnover is becoming less certain. For instance, in mice
genetically engineered to express type I collagen lacking a
functional cleavage sequence at the three-quarter site, no
phenotype was evident at birth. Only later did mild skin
thickening and uterine fibroses develop, implying that
alternative degradation mechanisms not requiring the
Available online http://arthritis-research.com/content/4/1/030
c
o
m
m
e
n
t
a
r
y
r
e
v
i
e
w
r
e
p
o
r
t
s
r
e
s
e
a
r
c
h
 
a
r
t
i
c
l
ethree-quarter cleavage can provide for essentially normal
development, growth and remodeling of most collagen
type I-based tissues [38].
This may also be true in articular cartilage. Collagenases,
although active at cleaving soluble monomers of collagen
(types I, II and III) in vitro, have limited activity against
cross-linked native fibrils. There is evidence to suspect,
based on findings with stromelysin-1 (MMP3) against
bovine cartilage collagen in vitro [39] and in considering
the placement of cross-links, that telopeptide cleavages
have to be critical early events in fibril depolymerization,
and that they may be the initiating event. In theory,
telopeptide cleavages alone could depolymerize a fibril if
they are internal to the cross-linking residue. Given the
complexity of the collagen II, IX and XI heteromer, and the
need for selective removal of collagen IX and perhaps XI
to allow for lateral growth of young fibrils, cleavages adja-
cent to the telopeptide cross-links are an attractive mech-
anism for cellular control of turnover. The large array of
matrix and membrane-associated proteases that chondro-
cytes can potentially express offers the basis for substrate
specificity and fine control of the temporal sequence of
collagen depolymerizing action. Perhaps collagenases
only come into play in tissues when a particularly rapid
degradation and a more efficient disposal of released
fibral monomers is required.
Collagen gene defects
The effects of mutations in cartilage collagen genes on the
matrix structure offer unique insights into the function of
the individual gene products. Collagen II mutations cause
a spectrum of diseases from lethal in utero (e.g. achondro-
genesis) to early-onset osteoarthritis and minimal skeletal
dysplasia [40]. Mutations in collagen IX genes have been
found to cause multiple epiphyseal dysplasia, as have
mutations in the cartilage oligomeric matrix protein gene
[41]. In COL9A2 and COL9A3, splice junction mutations
predicted deletion of the equivalent 12 amino acids
(exon 3) of the COL3 domain of α2(IX) or α3(IX) [42].
Protein analysis of iliac crest cartilage from an affected 10-
year-old boy heterozygous for the COL9A3 defect
showed collagen IX in the matrix, but showed evidence of
its inefficient cross-linking [43]. Two relatively common
polymorphisms that introduce a tryptophan residue into
the α2(IX) or α3(IX) chain have been shown to be linked
to an increased risk of lumbar disc disease [44]. Under-
standing their presumed negative effects on disc biology
is likely to be informative about collagen IX function.
Mutations in COL11A1 and COL2A1 have been found to
cause forms of Stickler and Marshall syndrome, in which
eye and/or cartilage problems are manifested [45].
Homozygous or compound heterozygous mutations in
COL11A2, which are predicted to cause a lack of α2(XI)
chains, underlie the recessively inherited otospondylo-
megaepiphyseal dysplasia syndrome [46]. The mecha-
nisms by which these and other collagen gene defects
disturb cartilage matrix assembly and function will be
important to define.
Conclusions
The collagenous matrix of articular cartilage is a highly
complex assemblage of multiple gene products. Neither
the functions of the individual components nor the molecu-
lar mechanisms controlling the assembly, turnover or
degradation in disease of the collagen heteropolymer are
yet well understood. Collagen breakdown is considered to
be a critical and perhaps irreversible step in the progres-
sion of osteoarthritis. Better insight into molecular mecha-
nisms by which chondrocytes control the functional
integrity of the collagenous component of adult articular
cartilage is needed.
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